Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer Eydelman Mikhail
Vaxcyte | 144: Notice of proposed sale of securities pursuant to Rule 144
Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer GUGGENHIME ANDREW
Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer Cowan Elvia
Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer Eydelman Mikhail
Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer Wassil Jim
Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer Wassil Jim
Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer PICKERING GRANT
Vaxcyte | 144: Notice of proposed sale of securities pursuant to Rule 144
Vaxcyte | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Vaxcyte | 10-K: FY2024 Annual Report
Vaxcyte | 8-K: Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer GUGGENHIME ANDREW
Vaxcyte | 144: Notice of proposed sale of securities pursuant to Rule 144
Vaxcyte | SCHEDULE 13G/A: Others
Vaxcyte | SCHEDULE 13G/A: Others
Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer Eydelman Mikhail
Vaxcyte | 144: Notice of proposed sale of securities pursuant to Rule 144
Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer Wassil Jim
Vaxcyte | 144: Notice of proposed sale of securities pursuant to Rule 144
Unlock the Full List